Measured by its ability to induce apoptosis of TF‑1 human erythroleukemic cells. The EC50 for this effect is less than10ng/ml.
Product Details
Product Details
Product Specification
Species | Human |
Synonyms | TL1; VEGI; Tumor Necrosis Factor Ligand Superfamily Member 15; TNF Ligand-Related Molecule 1; Vascular Endothelial Cell Growth Inhibitor |
Accession | O95150-1 |
Amino Acid Sequence | Leu72-Leu251 |
Expression System | E.coli |
Molecular Weight | 21kDa (Reducing) |
Purity | >95% by SDS-PAGE&RP-HPLC |
Endotoxin | <0.1EU/μg |
Conjugation | Unconjugated |
Tag | No Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer | 20mM Tris, 300mM NaCl, pH8.0 |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Reference | 1.2022 Jul 14:13:891328. eCollection 2022. |
Background
TNF-like cytokine 1A (TL1A) is a member of the TNF and TNF receptor superfamily. TL1A constitutes a cytokine system that actively interferes with the regulation of immune responses. TL-1A is predominantly expressed in endothelial cells and its expression is inducible by TNF-α and IL-1α. TL1A binds with high affinity to death receptor 3 (DR3), known as TNFRSF25. Recombinant human TL1A is a 21 kDa polypeptide of 180 amino acid residues
Picture
Picture
Bioactivity
SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).
RP-HPLC
